Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point (TTP)

November 17, 2022 updated by: University of Colorado, Denver
This study will evaluate a behavioral intervention designed to reduce risk factors for type 2 diabetes in American Indian youth aged 7-10 years.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

The objectives of tis study are to rigorously evaluate the effect of Tribal Turning Point (TTP) on diabetes risk factors in Native youth. The investigators will enroll up to 360 youth who are aged 7-10 years, overweight/obese (BMI >85th percentile), self-identify as American Indian, and have >1 parent/primary caregiver willing to actively participate in the program. Within each community, youth will be randomized to the TTP program or a general health and safety control program. The multi-component TTP intervention is a youth-centered adaptation of the Diabetes Prevention Program designed to reduce diabetes risk factors by improving activity and dietary behaviors. Informed by the pediatric weight management literature, the 12-month intervention includes 12 active learning group classes, 7 individual youth/parent motivational interviewing counseling sessions, and community-specific resource toolboxes. In this trial, the investigators will assess the effect of TTP on anthropometric, metabolic, and behavioral risk factors for type 2 diabetes at the end of the intervention (12mo) and after 1 year of follow-up (24mo).

Study Type

Interventional

Enrollment (Actual)

188

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • Childrens Hospital Colorado

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 10 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • self-identify as American Indian
  • BMI >=85th percentile for age and sex
  • have at least one parent/primary caregiver (parent) willing to actively participate

Exclusion Criteria:

  • diabetes
  • any serious youth/parent health concerns that would interfere with participation
  • plans to move out of the area during the study period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Active Living
Three component behavioral intervention consisting of group-based classes, individual motivational interviewing-based sessions, and resource toolbox
Participants will be provided with education and support for diet and lifestyle modification related to healthy eating and active living.
PLACEBO_COMPARATOR: Health and Safety
One component health and safety program consisting of group classes
Participants will be provided with education related to general health and safety topics.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change from 0 to 12 months in Body Mass Index (BMI)
Time Frame: 12 months
12 months
Change from 0 to 12 months in fasting insulin
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Change from 0 to 12 months in BMI z-score
Time Frame: 12 months
12 months
Change from 0 to 12 months in waist circumference
Time Frame: 12 months
12 months
Change from 0 to 12 months in hemoglobin A1c
Time Frame: 12 months
12 months
Change from 0 to 12 months in fasting glucose
Time Frame: 12 months
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from 0 to 12 months in fruit/vegetable intake
Time Frame: 12 months
Proportion consuming 5+ servings of fruits/vegetables daily
12 months
Change from 0 to 12 months in physical activity
Time Frame: 12 months
Proportion engaging in 1+ hour of moderate-vigorous physical activity daily
12 months
Change from 0 to 12 months in screen time
Time Frame: 12 months
Proportion watching 2 hours or less of screen time daily
12 months
Change from 0 to 12 months in sugary beverage intake
Time Frame: 12 months
Proportion consuming 0 servings of sugary beverages daily
12 months
Participant engagement
Time Frame: 12 months
Qualitative factors related to participant engagement
12 months
Program implementation
Time Frame: 12 months
Qualitative factors related to program implementation
12 months
Potential for sustained delivery
Time Frame: 12 months
Qualitative factors related to potential for sustained delivery
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2018

Primary Completion (ANTICIPATED)

September 1, 2023

Study Completion (ANTICIPATED)

September 1, 2023

Study Registration Dates

First Submitted

May 21, 2018

First Submitted That Met QC Criteria

June 19, 2018

First Posted (ACTUAL)

June 29, 2018

Study Record Updates

Last Update Posted (ACTUAL)

November 21, 2022

Last Update Submitted That Met QC Criteria

November 17, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 17-1306
  • R01DK115434 (NIH)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight/Obesity

Clinical Trials on Active Living

3
Subscribe